Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Rectal Neoplasms 1 Pruritus 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Pancreatic Adenocarcinoma 1 Overweight 1 Oropharyngeal Neoplasms 1 Opioid-Related Disorders 1 Obesity 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1

Interventions

X-Rays 1 Prednisolone 1 Endoscopy 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Barrett Esophagus × Blood Specimen Collection × Clear all

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡